Caxton Corp as of Sept. 30, 2025
Portfolio Holdings for Caxton Corp
Caxton Corp holds 12 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rezolute Com New (RZLT) | 81.7 | $19M | 2.0M | 9.40 | |
| Spdr Gold Tr Gold Shs (GLD) | 11.3 | $2.6M | 7.3k | 355.47 | |
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 1.4 | $328k | 651.00 | 503.00 | |
| Mind Medicine Mindmed Com New (MNMD) | 1.4 | $319k | 27k | 11.79 | |
| Enliven Therapeutics (ELVN) | 1.2 | $268k | 13k | 20.47 | |
| Compass Therapeutics (CMPX) | 0.8 | $187k | 54k | 3.50 | |
| Bicara Therapeutics (BCAX) | 0.8 | $173k | 11k | 15.79 | |
| Kyverna Therapeutics (KYTX) | 0.6 | $138k | 23k | 6.00 | |
| Lexeo Therapeutics (LXEO) | 0.5 | $115k | 17k | 6.64 | |
| Inhibikase Therapeutics Com New (IKT) | 0.1 | $27k | 16k | 1.62 | |
| Sab Biotherapeutics Com New (SABS) | 0.1 | $22k | 11k | 2.01 | |
| Context Therapeutics (CNTX) | 0.1 | $18k | 18k | 0.97 |
